Therapy of Parkinson's disease: are we at the end of the road?
Nag
D
D
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D015259:Dopamine Agents / Q000627:therapeutic use; D006801:Humans; D007194:India; D007980:Levodopa / Q000627:therapeutic use; D009460:Neurologic Examination / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy* / Q000209:etiology; D012642:Selegiline / Q000627:therapeutic use; D014810:Vitamin E / Q000627:therapeutic use
D000978:Antiparkinson Agents; D015259:Dopamine Agents; D014810:Vitamin E; D012642:Selegiline; D007980:Levodopa